CSI Addiction: Cognitive Screening In Addiction
More than a third of patients with substance use disorders who enroll in substance abuse treatment have cognitive impairments. Cognitive impairments influence treatment outcome and predict drop-out. Early detection of cognitive impairment is important in order to be able to tailor treatment accordingly and thus may increase positive treatment results and reduce dropout.
This project investigates whether early detection of cognitive impairments contributes to improving addiction care. By screening for cognitive function disorders at various times during addiction treatment, it is possible to determine at which moment and which cognitive domains are most predictive for treatment outcome. With this data, (neurocognitive) treatment can be better indicated and implemented in the future.
The research is a collaboration between the Academic Workplace Addiction of Arkin/Jellinek TOPGGz) and Amsterdam UMC (Psychiatry Department, location AMC).